Javascript must be enabled to continue!
RESEARCH ON THE DEVELOPMENT, VALIDATION ON SIMULTANEOUS QUANTIFICATION OF METOPROLOL SUCCINATE AND HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL DOSAGE FORMS USING RP-HPLC
View through CrossRef
A simple, accurate and precise High Performance Liquid Chromatographic (HPLC) method has been developed for simultaneous determination of Metoprolol Succinate and Hydrochlorothiazide in bulk and dosage form. The method has been validated as per the guidelines of ICH. The separation is achieved on 250*4.6mm C18, 5micron (Capcell) column with flow rate 1.0 mL/minute in isocratic mode using 0.1% OPA: Methanol (50:50) as mobile phase. Observations are recorded at 222 nm. The retention time of metoprolol succinate and hydrochlorothiazide were found at 3.25 min and 4.19 min respectively. The linearity range was found to be in the range of 10-50μg/ml for Metoprolol Succinate and Hydrochlorothiazide 5-25μg/ml. Correlation co-efficient for calibration curve of Metoprolol Succinate and Hydrochlorothiazide was found to be 0.999 and 0.990 respectively. The method is simple, accurate, reproducible and can be used for simultaneous analysis of Metoprolol Succinate and Hydrochlorothiazide.
Keywords: Metoprolol Succinate, Hydrochlorothiazide, OPA, Methanol
Title: RESEARCH ON THE DEVELOPMENT, VALIDATION ON SIMULTANEOUS QUANTIFICATION OF METOPROLOL SUCCINATE AND HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL DOSAGE FORMS USING RP-HPLC
Description:
A simple, accurate and precise High Performance Liquid Chromatographic (HPLC) method has been developed for simultaneous determination of Metoprolol Succinate and Hydrochlorothiazide in bulk and dosage form.
The method has been validated as per the guidelines of ICH.
The separation is achieved on 250*4.
6mm C18, 5micron (Capcell) column with flow rate 1.
0 mL/minute in isocratic mode using 0.
1% OPA: Methanol (50:50) as mobile phase.
Observations are recorded at 222 nm.
The retention time of metoprolol succinate and hydrochlorothiazide were found at 3.
25 min and 4.
19 min respectively.
The linearity range was found to be in the range of 10-50μg/ml for Metoprolol Succinate and Hydrochlorothiazide 5-25μg/ml.
Correlation co-efficient for calibration curve of Metoprolol Succinate and Hydrochlorothiazide was found to be 0.
999 and 0.
990 respectively.
The method is simple, accurate, reproducible and can be used for simultaneous analysis of Metoprolol Succinate and Hydrochlorothiazide.
Keywords: Metoprolol Succinate, Hydrochlorothiazide, OPA, Methanol.
Related Results
GREENNESS-ASSESSED ULTRAVIOLET AND REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHODS FOR AZELNIDIPINE–METOPROLOL SUCCINATE QUANTIFICATION IN TABLETS
GREENNESS-ASSESSED ULTRAVIOLET AND REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHODS FOR AZELNIDIPINE–METOPROLOL SUCCINATE QUANTIFICATION IN TABLETS
Objective: To ensure the quality control of fixed-dose antihypertensive formulations, it is essential to simultaneously estimate azelnidipine and metoprolol succinate. Although var...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Simultaneous spectrophotometric determination of valsartan and hydrochlorothiazide by H-point standard addition method and partial least squares regression
Simultaneous spectrophotometric determination of valsartan and hydrochlorothiazide by H-point standard addition method and partial least squares regression
Simultaneous spectrophotometric determination of valsartan and hydrochlorothiazide by H-point standard addition method and partial least squares regression
Simultaneous det...
Metoprolol therapy in patients with Eisenmenger syndrome (MINES) study. A single-centre, double-blinded, randomised, placebo-controlled trial
Metoprolol therapy in patients with Eisenmenger syndrome (MINES) study. A single-centre, double-blinded, randomised, placebo-controlled trial
Abstract
Background
Prevalence of Eisenmenger syndrome is still common in developing countries where early neonatal screening an...
Ketamine-induced ventricular structural, sympathetic and electrophysiologic remodelling: pathological consequences and protective effects of metoprolol
Ketamine-induced ventricular structural, sympathetic and electrophysiologic remodelling: pathological consequences and protective effects of metoprolol
Purpose
Growing evidence suggested long-term abuse of ketamine did harm to the heart and increased the risk of sudden death. The present study was performed to ex...
e0680 Relationship between polymorphism of ACE and the curative effect of metoprolol on chronic heart failure
e0680 Relationship between polymorphism of ACE and the curative effect of metoprolol on chronic heart failure
Objective
To investigate the effect of metoprolol on chronic heart failure and to discuss the relationship between polymorphism of ACE and the curative effect of ...
Differing Beta-Blocking Effects of Carvedilol and Metoprolol
Differing Beta-Blocking Effects of Carvedilol and Metoprolol
Abstract
Background
Metoprolol is a beta1-selective beta-adrenergic antagonist while carvedilol is a non-selective beta-b...

